FDA Inspection 1086637 — BodyBio Inc.

BodyBio Inc. — FEI 3003638959

The FDA completed an inspection of BodyBio Inc. on Apr 18, 2019 in Millville, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 18, 2019
Fiscal Year
2019
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Millville, NJ (United States)

Citations

IDCFRDescription
1554521 CFR 111.260(e)Batch record - component; identity, weight
1576221 CFR 111.205(a)Master manufacturing record - each batch
1586421 CFR 111.75(a)(2)(ii)(C)Documentation - qualify supplier

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.